Literature DB >> 3176426

[Effect of a new antiviral compound 1-morpholinomethyltetrahydro-2(1H)-pyrimidinone on the interaction of influenza virus proteins with flat lipid membranes].

V A Tverdislov, I G Kharitonenkov, S V Sukhanov, A S Galabov.   

Abstract

The antiviral preparation 1-morpholinomethyltetrahydro-2(1H)-pyrimidinone (abbreviation DD-13) inhibiting reproduction of certain enveloped viruses belonging to groups of orthomyxoviruses and alphaviruses, influenza type A viruses among them, inhibited adsorption and insertion of influenza virus M protein into model bilayer lipid membranes. The preparation did not interact directly with lipid bilayers but, after pretreatment of M protein with it, inhibited M protein interaction with the membranes: adsorption and insertion into the bilayer DD-13 did not affect the interaction of influenza virus surface glycoproteins with the model lipid membranes. It is concluded that the DD-13 preparation, not interacting with the membranes directly, in native systems may modify the protein-lipid interactions at the stages of virus penetration into the cell, penetration of M protein-coated nucleocapsid into the cell nucleus through the nuclear membrane, as well as at the stage of virus particle assembly on the plasma membrane of the infected cell.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3176426

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  2 in total

Review 1.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

Review 2.  Cycluridine: A novel antiviral effective against flaviviruses.

Authors:  Angel S Galabov; Lucia Mukova; Yuriy P Abashev; Lilia Wassilewa; Petko Tzvetkov; Vassil Minkov; Igor F Barinskiy; Charles M Rice; Sergey Ouzounov; Dorotea Sidzhakova
Journal:  Antivir Chem Chemother       Date:  2017-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.